Rheumatoid arthritis patients benefit from perisolimab when compared to a placebo, according to the NEJM.

Published Date: 21 Jul 2023

Peresolimab, a humanized IgG1 monoclonal, showed encouraging results in a phase 2a clinical trial, according to a recent study by Jay Tuttle and colleagues.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot